Detalhe da pesquisa
1.
Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia.
Haemophilia
; 29(1): 72-83, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195106
2.
Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.
Eur J Haematol
; 108(6): 518-527, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258118
3.
Real-world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow-up in a national adult cohort.
Haemophilia
; 27(4): 618-625, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939224
4.
Single centre, real-world experience of perioperative rFIXFc use in adult patients with haemophilia B undergoing major and minor surgery.
Haemophilia
; 27(6): e690-e697, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614282
5.
Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease.
Transfus Apher Sci
; 58(1): 58-60, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30551951
6.
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
J Thromb Haemost
; 21(5): 1123-1134, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775768
7.
Recombinant factor IX-Fc fusion protein in severe hemophilia B: Patient-reported outcomes and health-related quality of life.
Res Pract Thromb Haemost
; 5(7): e12602, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667923
8.
Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
Thromb Haemost
; 98(6): 1188-92, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18064312